Skip Navigation
Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
 
Slide Tray
0 slides

Return to Slide Library

Slides

Slides: 1–12 of 42
Add to tray Remove from tray

Introduction: Incidence of C.difficile Infection (CDI)

Presentation: Clostridium difficile Infections: Diagnosis, Treatment, and Prevention
Keywords: C. difficile Infection (CDI) | healthcare-associated infection | morbidity | mortality | incidence
Add to tray Remove from tray

Background: Characteristics of Osteoarthritis

Presentation: Analgesics for Osteoarthritis—An Update
Keywords: background | prevalence | characteristics
Add to tray Remove from tray

Gaps in Knowledge

Presentation: Angiotensin-Converting Enzyme Inhibitors (ACEIs), Angiotensin II Receptor Antagonists (ARBs), or Direct Renin Inhibitors (DRI) for Adults With Hypertension
Keywords: gaps in knowledge | future research | subgroups | clinical trials
Applicability Resources. Clinical experts and stakeholders can provide general information important to framing applicability issues. What does the population of interest looks like? What types of care or procedures are routine or represent standard of care? Are certain subpopulations characteristically different from others?
Add to tray Remove from tray

Applicability Resources

Presentation: Assessing Applicability
Keywords: Effective Health Care Program | comparative effectiveness review | stakeholder | population
Add to tray Remove from tray

Background: Epidemiology of Obstructive Sleep Apnea

Presentation: Diagnosis and Treatment of Obstructive Sleep Apnea in Adults
Keywords: symptoms | prevalence | background | epidemiology | public health
Add to tray Remove from tray

Other Findings: Influence of Patient Characteristics on Outcomes of DMARD Treatment

Presentation: Drug Therapy for Rheumatoid Arthritis in Adults
Keywords: adverse effects | anakinra | anti-rheumatic | antirheumatic | biologic DMARD | cardiovascular event | comorbidities | disease-modifying | DMARDs | methotrexate | methotrexate | oral DMARD | RA | renal impairment | rheumatoid arthritis
Add to tray Remove from tray

Knowledge Gaps and Future Research Needs (1 of 3)

Presentation: Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness
Keywords: knowledge gaps | future research needs | diabetes | studies | characteristics | populations | outcomes
Add to tray Remove from tray

Background

Presentation: Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research
Keywords: background | comparative effectiveness research | patient-centered outcomes
Add to tray Remove from tray

Summary of Study Characteristics Evaluated in the CER: The PICOTS Framework

Presentation: Non-surgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness
Keywords: adverse effects | comparators | mixed incontinence | outcomes | PICOTS | population | quality of life | setting | severity | stress incontinence | timing | urge incontinence | urgency incontinence | uinary incontinence
Add to tray Remove from tray

Conclusions About Benefits and Adverse Effects (2 of 2)

Presentation: Non-surgical Treatments for Urinary Incontinence in Adult Women: Diagnosis and Comparative Effectiveness
Keywords: Urinary incontinence | stress incontinence | urge incontinence | urgency incontinence | mixed incontinence | continence | diagnosis | voiding diary | cough stress test | prolapse | urinary tract infection | urodynamic evaluation | nonsurgical | questionnaire
Add to tray Remove from tray

Clinical Questions Addressed by the CER (4 of 4)

Presentation: Nonpharmacologic Interventions for Treatment-Resistant Depression in Adults
Keywords: key question | comparative effectiveness | systematic review
Add to tray Remove from tray

Adverse Effects of Interest in the Comparative Effectiveness Review

Presentation: Off-Label Use of Atypical Antipsychotics: An Update
Keywords: adverse events | atypical antipsychotics | cardiovascular events | diabetes | elderly | endocrine | extrapyramidal symptoms | mortality | off-label | second generation | sedation | weight | antipsychotics
Pages: [1] 2 3 4 Next
 
 
 
 
www.ahrq.gov AHRQ Home | Contact AHRQ | Site Map | Accessibility | Privacy Policy | Freedom of Information Act | Disclaimers
U.S. Department of Health & Human Services | The White House | USA.gov: The U.S. Government's Official Web Portal

Agency for Healthcare Research and Quality • 540 Gaither Road Rockville, MD 20850 • Telephone: (301) 427-1364